Cephalexin and Entresto drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cephalexin and Entresto. Common interactions include dyspnoea among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Cephalexin and Entresto have. It is created by eHealthMe based on reports of 31 people who take Cephalexin and Entresto from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

31 people who take Cephalexin and Entresto together, and have interactions are studied.


What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 23,608 Cephalexin users for its effectiveness, alternative drugs and more.

What is Entresto?

Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 68,542 Entresto users for its effectiveness, alternative drugs and more.

Number of Cephalexin and Entresto reports submitted per year:

Cephalexin and Entresto drug interactions.

Common Cephalexin and Entresto drug interactions by gender *:

female:

  1. Dyspnoea
  2. Fluid overload
  3. Hypotension
  4. Hypoxia
  5. Mucosal inflammation
  6. Lethargy
  7. Nausea
  8. Chronic kidney disease
  9. Diverticulitis
  10. Fall

male:

  1. Chronic kidney disease
  2. Renal failure
  3. Dyspnoea
  4. Lip swelling
  5. Myocardial infarction
  6. Pancreatitis
  7. Swelling face
  8. Tubulointerstitial nephritis
  9. Blood potassium increased
  10. Diabetic foot

Common Cephalexin and Entresto drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiac failure congestive
  2. Chronic kidney disease
  3. Hyperparathyroidism secondary
  4. Nephrogenic anaemia
  5. Pancreatitis
  6. Renal failure
  7. Renal injury
  8. Tubulointerstitial nephritis

50-59:

  1. Deep vein thrombosis
  2. Incision site erythema
  3. Limb discomfort
  4. Lower limb fracture
  5. Renal impairment

60+:

  1. Chronic kidney disease
  2. Hypotension
  3. Nausea
  4. Cardiac failure
  5. Cardiovascular disorder
  6. Fall
  7. Hyperparathyroidism secondary
  8. Myocardial infarction
  9. Pneumonia
  10. Lethargy

Common conditions people have *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 25.81%
  2. Pain: 7 people, 22.58%
  3. Multiple Myeloma (cancer of the plasma cells): 6 people, 19.35%
  4. Stress And Anxiety: 5 people, 16.13%
  5. Cardiac Failure: 5 people, 16.13%
  6. High Blood Pressure: 5 people, 16.13%
  7. High Blood Cholesterol: 5 people, 16.13%
  8. Anaemia (lack of blood): 4 people, 12.90%
  9. Diabetes: 4 people, 12.90%
  10. Renal Disorder (kidney disease): 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Cephalexin and Entresto?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cephalexin and Entresto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cephalexin interactions:

Browse all interactions between Cephalexin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Entresto interactions:

Browse all interactions between Entresto and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cephalexin and sacubitril; valsartan (the active ingredients of Cephalexin and Entresto, respectively), and Cephalexin and Entresto (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: